Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3.18M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
-311K
-
Total reported value, excl. options
-
$30.1M
-
Value change
-
+$1.06M
-
Put/Call ratio
-
0.06
-
Number of buys
-
18
-
Number of sells
-
-17
-
Price
-
$1.01
Significant Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q4 2023
59 filings reported holding PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (10.1M shares), Versant Venture Management, LLC (4.96M shares), Erste Asset Management GmbH (2.96M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), TANG CAPITAL MANAGEMENT LLC (2.4M shares), VANGUARD GROUP INC (2.02M shares), RENAISSANCE TECHNOLOGIES LLC (1.22M shares), BlackRock Inc. (1.02M shares), MILLENNIUM MANAGEMENT LLC (788K shares), and ACADIAN ASSET MANAGEMENT LLC (605K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.